tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Procept BioRobotics downgraded to Neutral from Buy at BofA
PremiumThe FlyProcept BioRobotics downgraded to Neutral from Buy at BofA
19d ago
Procept BioRobotics price target lowered to $51 from $56 at Morgan Stanley
Premium
The Fly
Procept BioRobotics price target lowered to $51 from $56 at Morgan Stanley
25d ago
Procept Biorobotics Earnings Call: Growth Amid Challenges
Premium
Company Announcements
Procept Biorobotics Earnings Call: Growth Amid Challenges
2M ago
Buy Rating Affirmed Amid Temporary Setbacks and Strategic Growth Prospects
PremiumRatingsBuy Rating Affirmed Amid Temporary Setbacks and Strategic Growth Prospects
2M ago
PROCEPT BioRobotics Reports Strong Q3 Growth and Optimistic 2026 Outlook
Premium
Company Announcements
PROCEPT BioRobotics Reports Strong Q3 Growth and Optimistic 2026 Outlook
2M ago
Josh Jennings Reaffirms Buy Rating on PROCEPT BioRobotics Amid Strong Q3 Results and Conservative 2026 Forecast
Premium
Ratings
Josh Jennings Reaffirms Buy Rating on PROCEPT BioRobotics Amid Strong Q3 Results and Conservative 2026 Forecast
2M ago
Procept Biorobotics’ WATER IV Study: A Game Changer in Prostate Cancer Treatment?
PremiumCompany AnnouncementsProcept Biorobotics’ WATER IV Study: A Game Changer in Prostate Cancer Treatment?
2M ago
Procept Biorobotics’ Aquablation Therapy Study: A Potential Game-Changer for Prostate Treatment
Premium
Company Announcements
Procept Biorobotics’ Aquablation Therapy Study: A Potential Game-Changer for Prostate Treatment
2M ago
Buy Rating Affirmed Amid Potential Upside and Strategic Leadership Changes
Premium
Ratings
Buy Rating Affirmed Amid Potential Upside and Strategic Leadership Changes
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100